first large study of glp 1 receptor agonists during pregnancy Taking GLP-1s the trimester does not appear to substantially increase the risk of adverse outcomes glp-1 pregnancy safety news today

Description

After 12 to 18 months, some patients may even be able to stop the GLP-1 drug and use FIM programming for weight maintenance

25 In the early 1990s, despite John Engs team identifying a potential diabetes treatment in exendin-4, it initially lacked attention and funding for development

In the U.K., Mounjaro is not yet recommended due to lack of sufficient evidence on efficacy and cost-effectiveness

Zucker I, Zloof Y, Bardugo A, Tsur AM, Lutski M, Cohen Y, et al

Contact Us: Persistence Market Research G04 Golden Mile House, Clayponds Lane Brentford, London, TW8 0GU UK USA Phone: +1 646-878-6329 UK Phone: +44 203-837-5656 Email: [email protected] Web: About Persistence Market Research: At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth